ARCHIVES

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 23 | June 18, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Amends FCRF RFP, Extends Deadline To Nov. 10

August 22, 1986

Joseph Jacobs, New Head Of alternative Medicine Office, Vows To ‘Talk Bluntly’

December 11, 1992

Maggie’s Bill Pays Off; NCI Celebrates 40th

August 12, 1977

Mason Asks For Better Technology Transfer In Cancer Prevention

October 30, 1992

Rejecting Data, Believers In PSA Screening Strengthen Guidelines, Launch Outreach

September 11, 2009

Edwards’ NIH Pep Talk Sounded Like An Attack On The Cancer Program, But He Says It Wasn’t

March 8, 1974